February 4, 2019
EyePoint Pharmaceuticals announces launch of YUTIQ
EyePoint Pharmaceuticals announces U.S. commercial launch of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg.
Independence Day schedule
We will be closed on Friday, July 3 in observance of the Independence Day holiday. Delivery operations may vary across our network. We encourage you to review our full holiday schedule for more detailed information and to plan your orders accordingly.